Robotic thoracic surgery for neurogenic tumors

Area of Science:

• Thoracic Surgery
• Surgical Oncology
• Robotic Surgery

Background:

• Thoracic neurogenic tumors are typically benign and resected via transthoracic or posterior approaches.
• Robot-assisted thoracic surgery (RATS) is emerging for transthoracic resections, but evidence remains limited.

Purpose of the Study:

• To evaluate the efficacy and safety of RATS for thoracic neurogenic tumors.
• To assess the outcomes of robotic resection in a high-volume thoracic surgery center.

Main Methods:

• Retrospective analysis of a prospectively maintained database of RATS surgeries from 2018-2023.
• Inclusion of all patients with histologically confirmed neurogenic tumors.
• Review of medical records, surgical data, and radiological/pathological findings.

Main Results:

• 27 patients underwent robotic resection of neurogenic tumors (schwannomas, ganglioneuromas, paraganglioma, neurofibroma).
• Median operative time was 69 minutes; median postoperative stay was 3 days.
• Low morbidity (lymphatic fistula, pneumonia, pain) and no perioperative mortality; neurological complications noted for thoracic apex tumors.

Conclusions:

• RATS is a feasible and safe method for thoracic neurogenic tumor resection.
• Thoracic apex tumors pose a higher risk for neurological deficits, requiring careful management.
• Interdisciplinary collaboration is crucial for optimal patient selection and outcomes.